The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Ursodeoxycholic acid for primary sclerosing cholangitis
Abstract
The effects of ursodeoxycholic acid (UDCA, 750-1250 mg/day) were evaluated prospectively in 15 patients with primary sclerosing cholangitis (PSC). Five patients had associated inflammatory bowel disease. After 6 months of treatment, the proportion of patients suffering from fatigue or pruritus decreased from 60% to 20% and from 33% to 20%, respectively. No exacerbation of associated disorders was observed. Serum alkaline phosphatase levels (normal less than 100 IU/l) decreased from 401 +/- 53 to 222 +/- 42 (mean +/- S.E.; p less than 0.001), those of gamma-glutamyl transpeptidase, (normal less than 40 IU/l) from 520 +/- 89 to 185 +/- 32 (p less than 0.001) and those of alanine aminotransferases, (normal less than 30 IU/l) from 79 +/- 12 to 42 +/- 6 (p less than 0.02). In three patients, the discontinuation of UDCA was associated with an aggravation of the liver test results. In conclusion, this study shows that 6 months of treatment with UDCA leads to clinical and biochemical improvements in patients with PSC. These results suggest that UDCA could be an effective treatment for PSC, and may justify a controlled therapeutic trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of smaller pilot studies and larger RCTs 13,80,[147][148][149][150][151][152][153][154][155][156] demonstrated improvement of serum liver tests (except for 2 of them 150,155 ), but these studies were all underpowered for the identification of”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [147]
Citations
Cites
IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?
Poupon, R., Poupon, R., Calmus, Y., Chrétien, Y., Ballet, F., & Darnis, F. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91610-2 · Cited by 536
Self-citationPrimary Sclerosing Cholangitis
LaRusso, N. F., Wiesner, R. H., Ludwig, J., & MacCarty, R. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404053101407 · Cited by 353
SchÖLmerich, J., Becher, M.-S., Schmidt, K., Schubert, R., Kremer, B., Feldhaus, S., & Gerok, W. (1984) · Hepatology · doi:10.1002/hep.1840040416 · Cited by 294
Primary Sclerosing Cholangitis
Dickson, R. E., Larusso, N. F., & Wiesner, R. H. (1984) · Hepatology · doi:10.1002/hep.1840040711 · Cited by 194
Wiesner, R. H., Larusso, N. F., Ludwig, J., & Rolland Dickson, E. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80141-4 · Cited by 193
Prospective trial of penicillamine in primary sclerosing cholangitis
LaRusso, N. F., Wiesner, R. H., Ludwig, J., MacCarty, R. L., Beaver, S. J., & Zinsmeister, A. R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90180-1 · Cited by 172
Improved survival with primary sclerosing cholangitis
Helzberg, J. H., Petersen, J. M., & Boyer, J. L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90618-4 · Cited by 166
Kaplan, M. M., ARORA, S., & PINCUS, S. H. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-231 · Cited by 78
Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients
Lebovics, E. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.4.729 · Cited by 69
Chrétien, Y., Poupon, R. Y., Gherardt, M. F., Chazouillères, O., Labbe, D., Myara, A., & Trivin, F. (1989) · Gut · doi:10.1136/gut.30.8.1110 · Cited by 48
Self-citation
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Ursodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-8006-6 · Cited by 581
Metadata
- Authors
- Chazouillères, O., Poupon, R., Capron, J.-P., Metman, E.-H., Dhumeaux, D., Amouretti, M., Couzigou, P., Labayle, D., & Trinchet, J.-C.
- Affiliations
- Hôpital Saint-Antoine (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Hôpital Xavier Arnozan (FR)
- Hôpital Jean-Verdier (FR)
- Corresponding author
- Poupon, Raoul
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 1990-07
- Volume
- 11
- Issue
- 1
- Pages
- 120-123
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1978726559
- Cited by
- 165
- References
- 11
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 3
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- ursodeoxycholic acid, primary sclerosing cholangitis, inflammatory bowel disease, fatigue, pruritus, serum alkaline phosphatase, gamma-glutamyl transferase, alanine aminotransferase, liver function tests, treatment discontinuation
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alkaline Phosphatase, Transaminases, Deoxycholic Acid, Female, gamma-Glutamyltransferase, Humans, Liver, Male, Middle Aged, Time Factors, Ursodeoxycholic Acid, Cholangitis, Sclerosing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ursodeoxycholic acid for primary sclerosing cholangitis. https://app.cochat.ai/papers/10.1016/0168-8278(90)90281-u
- The paper
- Chazouillères, O., Poupon, R., Capron, J.-P., Metman, E.-H., Dhumeaux, D., Amouretti, M., Couzigou, P., Labayle, D., & Trinchet, J.-C. (1990). Ursodeoxycholic acid for primary sclerosing cholangitis. Journal of Hepatology. https://doi.org/10.1016/0168-8278(90)90281-u
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.